{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:50:36Z","timestamp":1793731836633,"version":"4.6.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Identifying factors that influence problematic beliefs and behaviors related to pharmacotherapy may be useful for clinicians to improve the patients\u2019 adherence. The study aims to assess patients\u2019 beliefs about the necessity and concerns regarding pharmacotherapy in rheumatic diseases and attitude styles, and to investigate the association between clinical factors and negative beliefs about medication. A sample of 712 patients affected by Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis was enrolled. They were assessed using the Beliefs about Medicines Questionnaires-Specific (BMQ), the Simplified Disease Activity Index (SDAI), the Visual Analogue Scale for pain (VAS), the Chalder Fatigue Scale (CFQ) and the Health Assessment Questionnaire-Disability Index (HAQ-DI). The balance between benefits and costs in the BMQ-Specific was positive in the 79.4% of patients, negative in the 12.1% and equal in the 8.6%. SDAI, taking more than 5 medications, taking anti interleukin 6 (Anti-IL6) or biological disease-modifying antirheumatic drugs (bDMARDs), or targeted synthetic disease-modifying antirheumatic drugs (tsDMARDs), pain, and fatigue were significantly associated to higher Concerns. Having a longer disease duration was significantly associated with a higher Necessity, together with the current pharmacological treatments and the disability. The multivariate regression models estimated that higher pain and fatigue were associated to higher Concerns (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), while a longer disease duration (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and all pharmacological treatments for a rheumatologic disease (<jats:italic>p<\/jats:italic>\u2009=\u20090.001) were associated to higher Necessity levels. A high length of disease, a low level of remission, a high number of total medications, the prescription of an Anti-IL6\/bDMARDs\/tsDMARDs drug, a high level of pain, fatigue and disability identified patients potentially less adherent to pharmacotherapy to be carefully looked after by clinicians.<\/jats:p>","DOI":"10.1038\/s41598-022-27046-5","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T12:02:39Z","timestamp":1672401759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases"],"prefix":"10.1038","volume":"12","author":[{"given":"Sarah","family":"Tosato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bonetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Zanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Bixio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Marchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Pacenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isotta","family":"Galvagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doriana","family":"Cristofalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Fracassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Carletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,30]]},"reference":[{"issue":"6","key":"27046_CR1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0022-3999(99)00057-4","volume":"47","author":"R Horne","year":"1999","unstructured":"Horne, R. & Weinman, J. Patients\u2019 beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J. Psychosom. Res. 47(6), 555\u2013567 (1999).","journal-title":"J. Psychosom. Res."},{"issue":"4","key":"27046_CR2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/MAJ.0b013e3181e8bcb0","volume":"340","author":"I Contreras-Y\u00e1\u00f1ez","year":"2010","unstructured":"Contreras-Y\u00e1\u00f1ez, I., Cabiedes, J., Rull-Gabayet, M., Pascual-Ramos, V. & De Le\u00f3n, S. P. Inadequate therapy behavior is associated to disease flares in patients with rheumatoid arthritis who have achieved remission with disease-modifying antirheumatic drugs. Am. J. Med. Sci. 340(4), 282\u2013290 (2010).","journal-title":"Am. J. Med. Sci."},{"issue":"10","key":"27046_CR3","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1007\/s00296-011-2162-x","volume":"32","author":"R M\u00fcller","year":"2012","unstructured":"M\u00fcller, R., Kallikorm, R., P\u00f5lluste, K. & Lember, M. Compliance with treatment of rheumatoid arthritis. Rheumatol. Int. 32(10), 3131\u20133135 (2012).","journal-title":"Rheumatol. Int."},{"issue":"3","key":"27046_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2174\/1573397115666191212114758","volume":"16","author":"RA Grekhov","year":"2020","unstructured":"Grekhov, R. A., Suleimanova, G. P., Trofimenko, A. S. & Shilova, L. N. Psychosomatic features, compliance and complementary therapies in rheumatoid arthritis. Curr. Rheumatol. Rev. 16(3), 215\u2013223 (2020).","journal-title":"Curr. Rheumatol. Rev."},{"issue":"11","key":"27046_CR5","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00296-009-1160-8","volume":"30","author":"A de Thurah","year":"2010","unstructured":"de Thurah, A., N\u00f8rgaard, M., Harder, I. & Stengaard-Pedersen, K. Compliance with methotrexate treatment in patients with rheumatoid arthritis: Influence of patients\u2019 beliefs about the medicine. A prospective cohort study. Rheumatol. Int. 30(11), 1441\u20131448 (2010).","journal-title":"Rheumatol. Int."},{"key":"27046_CR6","doi-asserted-by":"crossref","unstructured":"Pasma, A., van't Spijker, A., Hazes, J. M., Busschbach, J. J., Luime, J. J. (eds) Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: A systematic review. In Seminars in Arthritis and Rheumatism (Elsevier, 2013).","DOI":"10.1016\/j.semarthrit.2012.12.001"},{"key":"27046_CR7","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2147\/PPA.S165101","volume":"12","author":"L-A Anghel","year":"2018","unstructured":"Anghel, L.-A., Farca\u015f, A. M. & Oprean, R. N. Medication adherence and persistence in patients with autoimmune rheumatic diseases: A narrative review. Patient Prefer. Adherence 12, 1151 (2018).","journal-title":"Patient Prefer. Adherence"},{"issue":"6","key":"27046_CR8","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ibd.20846","volume":"15","author":"R Horne","year":"2009","unstructured":"Horne, R., Parham, R., Driscoll, R. & Robinson, A. Patients\u2019 attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm. Bowel Dis. 15(6), 837\u2013844 (2009).","journal-title":"Inflamm. Bowel Dis."},{"issue":"6","key":"27046_CR9","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/rheumatology\/keh587","volume":"44","author":"R Neame","year":"2005","unstructured":"Neame, R. & Hammond, A. Beliefs about medications: A questionnaire survey of people with rheumatoid arthritis. Rheumatology 44(6), 762\u2013767 (2005).","journal-title":"Rheumatology"},{"issue":"12","key":"27046_CR10","doi-asserted-by":"publisher","first-page":"e80633","DOI":"10.1371\/journal.pone.0080633","volume":"8","author":"R Horne","year":"2013","unstructured":"Horne, R. et al. Understanding patients\u2019 adherence-related beliefs about medicines prescribed for long-term conditions: A meta-analytic review of the Necessity-Concerns Framework. PLoS ONE 8(12), e80633 (2013).","journal-title":"PLoS ONE"},{"issue":"4","key":"27046_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/medicina56040178","volume":"56","author":"A Turcu-Stiolica","year":"2020","unstructured":"Turcu-Stiolica, A. et al. The influence of socio-demographic factors, lifestyle and psychiatric indicators on adherence to treatment of patients with rheumatoid arthritis: A cross-sectional study. Medicina 56(4), 178 (2020).","journal-title":"Medicina"},{"key":"27046_CR12","doi-asserted-by":"publisher","DOI":"10.24926\/iip.v12i1.3584","author":"SH Abdulridha","year":"2021","unstructured":"Abdulridha, S. H., Kadhim, D. J. & Razzak, S. A. A. Beliefs about medicines among a sample of Iraqi patients with psoriasis. Innov. Pharm. https:\/\/doi.org\/10.24926\/iip.v12i1.3584 (2021).","journal-title":"Innov. Pharm."},{"issue":"1","key":"27046_CR13","doi-asserted-by":"publisher","first-page":"e000585","DOI":"10.1136\/rmdopen-2017-000585","volume":"5","author":"JS Smolen","year":"2019","unstructured":"Smolen, J. S. et al. Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: A large cross-sectional study. RMD Open 5(1), e000585 (2019).","journal-title":"RMD Open"},{"issue":"suppl_6","key":"27046_CR14","first-page":"vi6","volume":"51","author":"J Kay","year":"2012","unstructured":"Kay, J. & Upchurch, K. S. ACR\/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology 51(suppl_6), vi6\u2013vi9 (2012).","journal-title":"Rheumatology"},{"issue":"8","key":"27046_CR15","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor, W. et al. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis Rheum. Off. J. Am. Coll. Rheumatol. 54(8), 2665\u20132673 (2006).","journal-title":"Arthritis Rheum. Off. J. Am. Coll. Rheumatol."},{"issue":"6","key":"27046_CR16","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1136\/ard.2011.151563","volume":"70","author":"D van der Heijde","year":"2011","unstructured":"van der Heijde, D. et al. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann. Rheum. Dis. 70(6), 905\u2013908 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"27046_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-021-00214-3","author":"S Pezzato","year":"2021","unstructured":"Pezzato, S. et al. Depression is associated with increased disease activity and higher disability in a large Italian cohort of patients with rheumatoid arthritis. Adv. Rheumatol. https:\/\/doi.org\/10.1186\/s42358-021-00214-3 (2021).","journal-title":"Adv. Rheumatol."},{"key":"27046_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac445","author":"S Tosato","year":"2022","unstructured":"Tosato, S. et al. Coping strategies, emotional distress and perceived disease severity in a cohort of patients with rheumatoid arthritis: A mediation analysis. Rheumatology https:\/\/doi.org\/10.1093\/rheumatology\/keac445 (2022).","journal-title":"Rheumatology"},{"issue":"20","key":"27046_CR19","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"WM Association","year":"2013","unstructured":"Association, W. M. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 310(20), 2191\u20132194 (2013).","journal-title":"JAMA"},{"issue":"1","key":"27046_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08870449908407311","volume":"14","author":"R Horne","year":"1999","unstructured":"Horne, R., Weinman, J. & Hankins, M. The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol. Health 14(1), 1\u201324 (1999).","journal-title":"Psychol. Health"},{"issue":"1","key":"27046_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1017\/S1121189X00001640","volume":"19","author":"P Argentero","year":"2010","unstructured":"Argentero, P. et al. The beliefs about drug treatment. The Italian version of the BMQ (The Beliefs about Medicines Questionnaire): Its validity and applicability. Epidemiol. Psichiatr. Soc. 19(1), 86\u201392 (2010).","journal-title":"Epidemiol. Psichiatr. Soc."},{"issue":"2","key":"27046_CR22","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","volume":"42","author":"JS Smolen","year":"2003","unstructured":"Smolen, J. S. et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 42(2), 244\u2013257 (2003).","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"27046_CR23","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/ard.37.4.382","volume":"37","author":"WW Downie","year":"1978","unstructured":"Downie, W. W., Leatham, P. A., Rhind, V. M., Pickup, M. E. & Wright, V. The visual analogue scale in the assessment of grip strength. Ann. Rheum. Dis. 37(4), 382\u2013384 (1978).","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"27046_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0022-3999(93)90081-P","volume":"37","author":"T Chalder","year":"1993","unstructured":"Chalder, T. et al. Development of a fatigue scale. J. Psychosom. Res. 37(2), 147\u2013153 (1993).","journal-title":"J. Psychosom. Res."},{"issue":"5 Suppl 39","key":"27046_CR25","first-page":"S14","volume":"23","author":"B Bruce","year":"2005","unstructured":"Bruce, B. & Fries, J. F. The Health Assessment Questionnaire (HAQ). Clin. Exp. Rheumatol. 23(5 Suppl 39), S14\u2013S18 (2005).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4","key":"27046_CR26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2340\/00015555-3108","volume":"99","author":"ME Otero","year":"2019","unstructured":"Otero, M. E. et al. Beliefs about medicines in patients with psoriasis treated with methotrexate or biologics: A cross-sectional survey study. Acta Derm. Venereol. 99(4), 386\u2013392 (2019).","journal-title":"Acta Derm. Venereol."},{"issue":"7","key":"27046_CR27","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/rheumatology\/keh196","volume":"43","author":"D Berry","year":"2004","unstructured":"Berry, D., Bradlow, A. & Bersellini, E. Perceptions of the risks and benefits of medicines in patients with rheumatoid arthritis and other painful musculoskeletal conditions. Rheumatology (Oxford) 43(7), 901\u2013905 (2004).","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"27046_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/rheumatology\/keh116","volume":"43","author":"LJ Goodacre","year":"2004","unstructured":"Goodacre, L. J. & Goodacre, J. A. Factors influencing the beliefs of patients with rheumatoid arthritis regarding disease-modifying medication. Rheumatology (Oxford) 43(5), 583\u2013586 (2004).","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"27046_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/2168479013481968","volume":"47","author":"P Matoulkova","year":"2013","unstructured":"Matoulkova, P. et al. Chronically Ill Czech patients\u2019 beliefs about medicines: The psychometric properties and factor structure of the BMQ-CZ. Ther. Innov. Regul. Sci. 47(3), 341\u2013348 (2013).","journal-title":"Ther. Innov. Regul. Sci."},{"issue":"1","key":"27046_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12325-016-0441-3","volume":"34","author":"P Michetti","year":"2017","unstructured":"Michetti, P. et al. Impact of treatment-related beliefs on medication adherence in immune-mediated inflammatory diseases: Results of the global ALIGN study. Adv. Ther. 34(1), 91\u2013108 (2017).","journal-title":"Adv. Ther."},{"key":"27046_CR31","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.2147\/PPA.S66849","volume":"8","author":"HE Zwikker","year":"2014","unstructured":"Zwikker, H. E., van Dulmen, S., den Broeder, A. A., van den Bemt, B. J. & van den Ende, C. H. Perceived need to take medication is associated with medication non-adherence in patients with rheumatoid arthritis. Patient Prefer. Adherence 8, 1635\u20131645 (2014).","journal-title":"Patient Prefer. Adherence"},{"issue":"2","key":"27046_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/1742395309102888","volume":"5","author":"G Tibaldi","year":"2009","unstructured":"Tibaldi, G. et al. The utility of the Necessity-Concerns Framework in explaining treatment non-adherence in four chronic illness groups in Italy. Chronic Illn. 5(2), 129\u2013133 (2009).","journal-title":"Chronic Illn."},{"issue":"1","key":"27046_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jpsychores.2007.07.016","volume":"64","author":"TT Menckeberg","year":"2008","unstructured":"Menckeberg, T. T. et al. Beliefs about medicines predict refill adherence to inhaled corticosteroids. J. Psychosom. Res. 64(1), 47\u201354 (2008).","journal-title":"J. Psychosom. Res."},{"key":"27046_CR34","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.2147\/PPA.S166451","volume":"12","author":"R Horne","year":"2018","unstructured":"Horne, R., Albert, A. & Boone, C. Relationship between beliefs about medicines, adherence to treatment, and disease activity in patients with rheumatoid arthritis under subcutaneous anti-TNF\u03b1 therapy. Patient Prefer. Adherence 12, 1099\u20131111 (2018).","journal-title":"Patient Prefer. Adherence"},{"issue":"8","key":"27046_CR35","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1177\/0961203311398512","volume":"20","author":"K Kumar","year":"2011","unstructured":"Kumar, K. et al. \u201cIt\u2019s like taking poison to kill poison but I have to get better\u201d: A qualitative study of beliefs about medicines in Rheumatoid arthritis and Systemic lupus erythematosus patients of South Asian origin. Lupus 20(8), 837\u2013844 (2011).","journal-title":"Lupus"},{"issue":"1","key":"27046_CR36","first-page":"213","volume":"59","author":"HF Hope","year":"2020","unstructured":"Hope, H. F. et al. The predictors of and reasons for non-adherence in an observational cohort of patients with rheumatoid arthritis commencing methotrexate. Rheumatology (Oxford) 59(1), 213\u2013223 (2020).","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"27046_CR37","first-page":"2469","volume":"30","author":"E de Klerk","year":"2003","unstructured":"de Klerk, E., van der Heijde, D., Landew\u00e9, R., van der Tempel, H. & van der Linden, S. The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: A validation study. J. Rheumatol. 30(11), 2469\u20132475 (2003).","journal-title":"J. Rheumatol."},{"issue":"7","key":"27046_CR38","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1111\/bcp.14193","volume":"86","author":"AHY Chan","year":"2020","unstructured":"Chan, A. H. Y., Horne, R., Hankins, M. & Chisari, C. The Medication Adherence Report Scale: A measurement tool for eliciting patients\u2019 reports of nonadherence. Br. J. Clin. Pharmacol. 86(7), 1281\u20131288 (2020).","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27046-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27046-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27046-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T12:04:23Z","timestamp":1672401863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27046-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["27046"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-27046-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,30]]},"assertion":[{"value":"29 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22603"}}